Drug
Landiolol clinical trials
Also written ONO-1101.
- studies test it
- 16
- open now
- 4
- in phase 3
- 7
- first study started
- 1996
Keep track of what changes. Save the landiolol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
16 studies that test it; most in 2021 (4)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 2001 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2019 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 6
- Phase 3
- 7
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 9
Ono Pharmaceutical Co. Ltd (4) · AOP Orphan Pharmaceuticals AG (2) · Medical University of Vienna (2) · CMC Ambroise Paré (1) · Hospices Civils de Lyon (1) · Ono Pharma USA Inc (1) · Insel Gruppe AG, University Hospital Bern (1) · Università Vita-Salute San Raffaele (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses landiolol is read from its arms, and is right about nine times in ten.
Testing it · 16
- LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac SurgeryRecruitingPhase 4Insel Gruppe AG, University Hospital BernNCT07168421Written as Landiolol
- Landiolol in Mitral Valve SurgeryRecruitingPhase 4Università Vita-Salute San RaffaeleNCT06793670Written as Landiolol
- Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With HypercontractilityRecruitingPhase 3Centre Hospitalier Universitaire, AmiensNCT04748796Written as Landiolol
- LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)RecruitingPhase 3Assistance Publique - Hôpitaux de ParisNCT04931225Written as Landiolol
- Prevention of Atrial Fibrillation by Low-dose Landiolol Administration After Cardiac SurgeryCompletedPhase 3CMC Ambroise ParéNCT04607122Written as Landiolol
- Landiolol in Postoperative Atrial FibrillationCompletedPhase 3Hospices Civils de LyonNCT03779178Written as Landiolol
- Beta-blockade With Landiolol in Out-of-hospital Cardiac ArrestStatus unknownPhase 1/2Medical University of ViennaNCT05554978Written as Landiolol
- Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac SurgeryStatus unknownPhase 3Medical University of ViennaNCT05084118Written as Landiolol HCl
- Comparison of Two Strategies for the Management of Atrial Fibrillation After Cardiac SurgeryStatus unknownPhase 4University Hospital, CaenNCT04223739Written as Landiolol
- Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy VolunteersCompletedPhase 1AOP Orphan Pharmaceuticals AGNCT01741519Written as LDLL600
- Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in JapanCompletedPhase 2Ono Pharma USA IncNCT00212680Written as ONO-1101
- Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in JapanCompletedPhase 2/3Ono Pharmaceutical Co. LtdNCT00212654Written as ONO-1101
- A Short Term Pharmacokinetic, Pharmacodynamic and Tolerability Study to Compare AOP200704 vs. EsmololCompletedPhase 2AOP Orphan Pharmaceuticals AGNCT01313143Written as AOP200704
- Study of ONO-1101 in Patients Scheduled for Multi-Slice Computed Tomography (CT)CompletedPhase 3Ono Pharmaceutical Co. LtdNCT00924586Written as ONO-1101
- Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CTCompletedPhase 2Ono Pharmaceutical Co. LtdNCT00311038Written as ONO-1101
- Study of ONO-1101 in Patients Scheduled for Coronary AngiographyCompletedPhase 2Ono Pharmaceutical Co. LtdNCT00560209Written as ONO-1101
Codes
What other systems call landiolol · ClinicalTrials.gg INT003662
- MeSH (NLM) C077049landiololConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 62NWQ924LHLANDIOLOLConfirmed FDA, NLM, Wikidata
- Wikidata Q6484656landiololConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C79125LandiololOne source FDA
- DrugBank DB12212One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C077049 | landiolol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 62NWQ924LH | LANDIOLOL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6484656 | landiolol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C79125 | Landiolol | One source FDA |
| DrugBank | DB12212 | — | One source Wikidata |
Also registered as landiolol hydrochloride (UNII G8HQ634Y17).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.